Case report on renal failure reversal in lambda chain multiple myeloma with bortezomib and dexamethasone.
Identifieur interne : 003885 ( PubMed/Checkpoint ); précédent : 003884; suivant : 003886Case report on renal failure reversal in lambda chain multiple myeloma with bortezomib and dexamethasone.
Auteurs : Bhanu K. Patibandla [États-Unis] ; Akshita Narra [États-Unis] ; Ahmad A. Alwassia [États-Unis] ; Anthony Bartley [États-Unis] ; Gurprataap S. Sandhu [États-Unis] ; James Rooney [États-Unis] ; Robert M. Black [États-Unis]Source :
- Case reports in nephrology [ 2090-6641 ] ; 2014.
Abstract
Renal failure (RF) reversal in multiple myeloma (MM) is associated with an improved prognosis. Light chain myeloma, serum creatinine (SCr) > 4 mg/dL, extensive proteinuria, early infections, and certain renal biopsy findings are associated with lower rates of RF reversal. Our patient is a 67-year-old female with multiple poor prognostic factors for RF reversal who demonstrated a rapid renal response with bortezomib and dexamethasone (BD) regimen. She presented initially with altered mental status. On exam, she appeared lethargic and dehydrated and had generalized tenderness. She had been taking ibuprofen as needed for pain for a few weeks. Labs showed a white cell count-18,900/μL with no bandemia, hemoglobin 10.8 gm/dL, potassium-6.7 mEq/L, bicarbonate-15 mEq/L, blood urea nitrogen-62 mg/dL, SCr-5.6 mg/dL (baseline: 1.10), and corrected calcium-11.8 mg/dL. A rapid flu test was positive. Imaging studies were unremarkable. Her EKG showed sinus tachycardia and her urinalysis was unremarkable. The unexplained RF in an elderly individual in conjunction with hypercalcemia and anemia prompted a MM work-up; eventually, lambda variant MM was diagnosed. An immediate (4 days) renal response defined as 50% reduction in SCr was noticed after initiation of the BD regimen.
DOI: 10.1155/2014/940171
PubMed: 25045553
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25045553Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Case report on renal failure reversal in lambda chain multiple myeloma with bortezomib and dexamethasone.</title><author><name sortKey="Patibandla, Bhanu K" sort="Patibandla, Bhanu K" uniqKey="Patibandla B" first="Bhanu K" last="Patibandla">Bhanu K. Patibandla</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Narra, Akshita" sort="Narra, Akshita" uniqKey="Narra A" first="Akshita" last="Narra">Akshita Narra</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of Connecticut, Farmington, CT 06030, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of Connecticut, Farmington, CT 06030</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Alwassia, Ahmad A" sort="Alwassia, Ahmad A" uniqKey="Alwassia A" first="Ahmad A" last="Alwassia">Ahmad A. Alwassia</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Bartley, Anthony" sort="Bartley, Anthony" uniqKey="Bartley A" first="Anthony" last="Bartley">Anthony Bartley</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Sandhu, Gurprataap S" sort="Sandhu, Gurprataap S" uniqKey="Sandhu G" first="Gurprataap S" last="Sandhu">Gurprataap S. Sandhu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of Pittsburgh Medical Centre, 200 Lothrop Street, Pittsburgh, PA 15206, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of Pittsburgh Medical Centre, 200 Lothrop Street, Pittsburgh, PA 15206</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Rooney, James" sort="Rooney, James" uniqKey="Rooney J" first="James" last="Rooney">James Rooney</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Black, Robert M" sort="Black, Robert M" uniqKey="Black R" first="Robert M" last="Black">Robert M. Black</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25045553</idno><idno type="pmid">25045553</idno><idno type="doi">10.1155/2014/940171</idno><idno type="wicri:Area/PubMed/Corpus">004225</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004225</idno><idno type="wicri:Area/PubMed/Curation">004187</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004187</idno><idno type="wicri:Area/PubMed/Checkpoint">004187</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004187</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Case report on renal failure reversal in lambda chain multiple myeloma with bortezomib and dexamethasone.</title><author><name sortKey="Patibandla, Bhanu K" sort="Patibandla, Bhanu K" uniqKey="Patibandla B" first="Bhanu K" last="Patibandla">Bhanu K. Patibandla</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Narra, Akshita" sort="Narra, Akshita" uniqKey="Narra A" first="Akshita" last="Narra">Akshita Narra</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of Connecticut, Farmington, CT 06030, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of Connecticut, Farmington, CT 06030</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Alwassia, Ahmad A" sort="Alwassia, Ahmad A" uniqKey="Alwassia A" first="Ahmad A" last="Alwassia">Ahmad A. Alwassia</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Bartley, Anthony" sort="Bartley, Anthony" uniqKey="Bartley A" first="Anthony" last="Bartley">Anthony Bartley</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Sandhu, Gurprataap S" sort="Sandhu, Gurprataap S" uniqKey="Sandhu G" first="Gurprataap S" last="Sandhu">Gurprataap S. Sandhu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of Pittsburgh Medical Centre, 200 Lothrop Street, Pittsburgh, PA 15206, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of Pittsburgh Medical Centre, 200 Lothrop Street, Pittsburgh, PA 15206</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Rooney, James" sort="Rooney, James" uniqKey="Rooney J" first="James" last="Rooney">James Rooney</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Black, Robert M" sort="Black, Robert M" uniqKey="Black R" first="Robert M" last="Black">Robert M. Black</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author></analytic><series><title level="j">Case reports in nephrology</title><idno type="ISSN">2090-6641</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Renal failure (RF) reversal in multiple myeloma (MM) is associated with an improved prognosis. Light chain myeloma, serum creatinine (SCr) > 4 mg/dL, extensive proteinuria, early infections, and certain renal biopsy findings are associated with lower rates of RF reversal. Our patient is a 67-year-old female with multiple poor prognostic factors for RF reversal who demonstrated a rapid renal response with bortezomib and dexamethasone (BD) regimen. She presented initially with altered mental status. On exam, she appeared lethargic and dehydrated and had generalized tenderness. She had been taking ibuprofen as needed for pain for a few weeks. Labs showed a white cell count-18,900/μL with no bandemia, hemoglobin 10.8 gm/dL, potassium-6.7 mEq/L, bicarbonate-15 mEq/L, blood urea nitrogen-62 mg/dL, SCr-5.6 mg/dL (baseline: 1.10), and corrected calcium-11.8 mg/dL. A rapid flu test was positive. Imaging studies were unremarkable. Her EKG showed sinus tachycardia and her urinalysis was unremarkable. The unexplained RF in an elderly individual in conjunction with hypercalcemia and anemia prompted a MM work-up; eventually, lambda variant MM was diagnosed. An immediate (4 days) renal response defined as 50% reduction in SCr was noticed after initiation of the BD regimen.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">25045553</PMID><DateCreated><Year>2014</Year><Month>07</Month><Day>21</Day></DateCreated><DateCompleted><Year>2014</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2090-6641</ISSN><JournalIssue CitedMedium="Print"><Volume>2014</Volume><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Case reports in nephrology</Title><ISOAbbreviation>Case Rep Nephrol</ISOAbbreviation></Journal><ArticleTitle>Case report on renal failure reversal in lambda chain multiple myeloma with bortezomib and dexamethasone.</ArticleTitle><Pagination><MedlinePgn>940171</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1155/2014/940171</ELocationID><Abstract><AbstractText>Renal failure (RF) reversal in multiple myeloma (MM) is associated with an improved prognosis. Light chain myeloma, serum creatinine (SCr) > 4 mg/dL, extensive proteinuria, early infections, and certain renal biopsy findings are associated with lower rates of RF reversal. Our patient is a 67-year-old female with multiple poor prognostic factors for RF reversal who demonstrated a rapid renal response with bortezomib and dexamethasone (BD) regimen. She presented initially with altered mental status. On exam, she appeared lethargic and dehydrated and had generalized tenderness. She had been taking ibuprofen as needed for pain for a few weeks. Labs showed a white cell count-18,900/μL with no bandemia, hemoglobin 10.8 gm/dL, potassium-6.7 mEq/L, bicarbonate-15 mEq/L, blood urea nitrogen-62 mg/dL, SCr-5.6 mg/dL (baseline: 1.10), and corrected calcium-11.8 mg/dL. A rapid flu test was positive. Imaging studies were unremarkable. Her EKG showed sinus tachycardia and her urinalysis was unremarkable. The unexplained RF in an elderly individual in conjunction with hypercalcemia and anemia prompted a MM work-up; eventually, lambda variant MM was diagnosed. An immediate (4 days) renal response defined as 50% reduction in SCr was noticed after initiation of the BD regimen.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patibandla</LastName><ForeName>Bhanu K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narra</LastName><ForeName>Akshita</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4345-0178</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Connecticut, Farmington, CT 06030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alwassia</LastName><ForeName>Ahmad A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartley</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandhu</LastName><ForeName>Gurprataap S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Pittsburgh Medical Centre, 200 Lothrop Street, Pittsburgh, PA 15206, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rooney</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Robert M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Saint Vincent Hospital, University of Massachusetts School of Medicine, 123 Summer Street, Worcester, MA 01608, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Case Rep Nephrol</MedlineTA><NlmUniqueID>101598418</NlmUniqueID><ISSNLinking>2090-665X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1944 Mar;23(2):163-6</RefSource><PMID Version="1">16695090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Nephrol Necker Hosp. 1992;21:347-70</RefSource><PMID Version="1">1566651</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Contrib Nephrol. 2011;169:262-9</RefSource><PMID Version="1">21252525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Lab Clin Med. 1987 Oct;110(4):460-5</RefSource><PMID Version="1">3655525</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Chronic Kidney Dis. 2012 Sep;19(5):342-51</RefSource><PMID Version="1">22920645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 1998 Sep 28;158(17):1889-93</RefSource><PMID Version="1">9759684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nephrol Dial Transplant. 1998 Jun;13(6):1438-45</RefSource><PMID Version="1">9641173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2010;15(1):6-25</RefSource><PMID Version="1">20086168</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bone Marrow Transplant. 2004 Apr;33(8):823-8</RefSource><PMID Version="1">14767499</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Res. 2010 Oct;34(10):1395-7</RefSource><PMID Version="1">20510452</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2008 Apr;22(4):842-9</RefSource><PMID Version="1">18200040</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trials. 2008 Sep 28;9:55</RefSource><PMID Version="1">18822172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Haematologica. 2009 Mar;94(3):372-9</RefSource><PMID Version="1">19252175</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Hematol. 2012 Feb;5(1):51-66; quiz 67-8</RefSource><PMID Version="1">22272706</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lab Invest. 1991 Apr;64(4):527-37</RefSource><PMID Version="1">1901926</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Kidney Dis. 2012 Jun;59(6):786-94</RefSource><PMID Version="1">22417785</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 1967 Aug 1;126(2):207-21</RefSource><PMID Version="1">4165739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Chronic Kidney Dis. 2012 Sep;19(5):282-6</RefSource><PMID Version="1">22920637</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Adv Chronic Kidney Dis. 2012 Sep;19(5):312-23</RefSource><PMID Version="1">22920642</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br Med J. 1976 Feb 28;1(6008):503-4</RefSource><PMID Version="1">1252820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Chemother Pharmacol. 2011 Dec;68(6):1439-47</RefSource><PMID Version="1">21479634</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2005 Dec 20;23(36):9219-26</RefSource><PMID Version="1">16275935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ren Fail. 2000;22(4):465-77</RefSource><PMID Version="1">10901184</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Pharmacol Exp Ther. 2008 Dec;327(3):645-56</RefSource><PMID Version="1">18776064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 2003 Jul;122(1):160-1</RefSource><PMID Version="1">12823359</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2011 Sep 15;365(11):1061; author reply 1062</RefSource><PMID Version="1">21916654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Kidney Int. 1995 Oct;48(4):1347-61</RefSource><PMID Version="1">8569099</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2009 Sep;23(9):1545-56</RefSource><PMID Version="1">19421229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leukemia. 2008 Aug;22(8):1485-93</RefSource><PMID Version="1">18528426</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2010 Nov 20;28(33):4976-84</RefSource><PMID Version="1">20956629</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Blood. 2007 Mar 15;109(6):2604-6</RefSource><PMID Version="1">17138816</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2011 Jun 16;364(24):2365-6</RefSource><PMID Version="1">21675906</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Lymphoma Myeloma. 2009 Aug;9(4):302-6</RefSource><PMID Version="1">19717380</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Haematol. 2000 Sep;65(3):175-81</RefSource><PMID Version="1">11007053</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Haematol. 1995 Dec;91(4):854-9</RefSource><PMID Version="1">8547129</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Leuk Lymphoma. 2007 Oct;48(10):1910-21</RefSource><PMID Version="1">17917960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Haematol. 2006;116(4):255-8</RefSource><PMID Version="1">17119326</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Nephrol. 1990 Dec;34(6):247-54</RefSource><PMID Version="1">2073767</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Medicine (Baltimore). 1987 Mar;66(2):126-37</RefSource><PMID Version="1">3102893</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Assoc Physicians India. 2009 Jan;57:23-6</RefSource><PMID Version="1">19753754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1990 Feb;85(2):570-6</RefSource><PMID Version="1">2298921</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pol Arch Med Wewn. 2012;122(9):443-8</RefSource><PMID Version="1">22983189</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Kidney Int. 2008 Jun;73(11):1282-8</RefSource><PMID Version="1">18385667</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Haematologica. 2007 Apr;92(4):546-9</RefSource><PMID Version="1">17488666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 1992 Feb;89(2):630-9</RefSource><PMID Version="1">1737851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Nephrol. 1987 Jul;28(1):1-9</RefSource><PMID Version="1">3621685</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Contrib Nephrol. 2007;153:87-104</RefSource><PMID Version="1">17075225</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vnitr Lek. 2009 Jun;55(6):570-82</RefSource><PMID Version="1">19662889</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Lymphoma Myeloma. 2009 Oct;9(5):394-8</RefSource><PMID Version="1">19858061</PMID></CommentsCorrections></CommentsCorrectionsList><OtherID Source="NLM">PMC4089941</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>04</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>06</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25045553</ArticleId><ArticleId IdType="doi">10.1155/2014/940171</ArticleId><ArticleId IdType="pmc">PMC4089941</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Connecticut</li><li>Massachusetts</li><li>Pennsylvanie</li></region></list><tree><country name="États-Unis"><region name="Massachusetts"><name sortKey="Patibandla, Bhanu K" sort="Patibandla, Bhanu K" uniqKey="Patibandla B" first="Bhanu K" last="Patibandla">Bhanu K. Patibandla</name></region><name sortKey="Alwassia, Ahmad A" sort="Alwassia, Ahmad A" uniqKey="Alwassia A" first="Ahmad A" last="Alwassia">Ahmad A. Alwassia</name><name sortKey="Bartley, Anthony" sort="Bartley, Anthony" uniqKey="Bartley A" first="Anthony" last="Bartley">Anthony Bartley</name><name sortKey="Black, Robert M" sort="Black, Robert M" uniqKey="Black R" first="Robert M" last="Black">Robert M. Black</name><name sortKey="Narra, Akshita" sort="Narra, Akshita" uniqKey="Narra A" first="Akshita" last="Narra">Akshita Narra</name><name sortKey="Rooney, James" sort="Rooney, James" uniqKey="Rooney J" first="James" last="Rooney">James Rooney</name><name sortKey="Sandhu, Gurprataap S" sort="Sandhu, Gurprataap S" uniqKey="Sandhu G" first="Gurprataap S" last="Sandhu">Gurprataap S. Sandhu</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003885 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003885 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:25045553
|texte= Case report on renal failure reversal in lambda chain multiple myeloma with bortezomib and dexamethasone.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25045553" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |